Wanyuan (Fuzhou) Pharmaceutical Co., Ltd. is a pharmaceutical company invested in China by Hong Kong Yonglong (Nanyang) Group, located in Fuxing Investment Zone, Jin'an District, Fuzhou City. The factory is designed according to GMP planning and design, covering an area of ​​20,000 square meters, with a construction area of ​​about 25,000 square meters, and has four workshops, including tablets, capsules, granules, liniments, ointments, suppositories, oral liquids, oral treatments. 8 dosage forms of solution agent and 26 varieties.

The company currently has 95 employees and implements the general manager responsibility system under the leadership of the board of directors. Production, quality and sales are respectively responsible for the deputy general manager in charge. It has six departments including the production department, the quality assurance department, the finance department, the logistics department, the sales department, and the comprehensive office. Each department has clear functions and job responsibilities of personnel at all levels. It is also equipped with a team of managers with corresponding education, experience in drug production management, and a group of employees who have professional knowledge and skills and can produce according to GMP requirements. The company's production director, quality director, and quality assurance department manager are responsible for the implementation of GMP and product quality. Responsible for the entire process of the company's production and quality management, and can make correct judgments on practical issues in drug production and quality management. The company has 27 professional and technical personnel, 9 of them have intermediate and senior professional titles or above, and 3 have obtained the qualification of practicing pharmacist, and technicians account for 28% of the total number of employees.

The company's existing tablets, capsules, liniments, oral liquid dosage forms and production lines all passed the national GMP certification in 2004 and passed the second national GMP certification in 2009. The certificate number is K0164. Since 2008, While focusing on production and operation, the company pays attention to the company's technological innovation and technological transformation work. It has successively invested a lot of funds in the development of new products and the implementation of GMP transformation. On September 22, 2009, it obtained ambroxol hydrochloride oral solution medicines. Registration approval document, new production scope of production license on February 8, 2010: oral solution agent. The company has adapted the factory equipment and facilities of the oral solution production line, revised the company's quality management, production management and other documents, trained personnel, and conducted major equipment, processes, purification systems and water production. The system has been verified and reverified.

The Yonglong brand series of drugs produced by the company have been well received by patients. The company has been awarded the honorable title of "Enthusiastic Public Welfare" by China Charity Fund many times.

Under the leadership of General Manager Hong Chunming, the company promotes the spirit of "making good medicines for the people", strictly organizes production and operation in accordance with the requirements of the "Drug Management Law" and "Drug Production Quality Management Standards", and has full enthusiasm and firm beliefs, Excellent technology and high-quality services meet future challenges and make due contributions to the development of the medical industry in the West Coast of Fujian Strait.